Clinical Trials on Diffuse Intrinsic Pontine Glioma in Australia

Total 12 results

  • University of California, San Francisco
    National Institute of Neurological Disorders and Stroke (NINDS); The Chad-Tough... and other collaborators
    Recruiting
    Combination Therapy for the Treatment of Diffuse Midline Gliomas
    Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Diffuse Midline Glioma, H3 K27M-Mutant | Recurrent WHO Grade III Glioma | WHO Grade III Glioma
    United States, Israel, Australia, Netherlands, Switzerland, New Zealand
  • University of Calgary
    Recruiting
    Re-Irradiation of Progressive or Recurrent DIPG
    Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
    Canada, Australia, New Zealand
  • Nationwide Children's Hospital
    Recruiting
    A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
    High Grade Glioma | Diffuse Intrinsic Pontine Glioma
    United States, Australia, Canada, Germany
  • Nationwide Children's Hospital
    Novartis
    Not yet recruiting
    Study of Ribociclib and Everolimus in HGG and DIPG
    Glioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | WHO Grade IV Glioma
    United States, Australia, United Kingdom, Canada, Germany, Netherlands
  • Nationwide Children's Hospital
    Not yet recruiting
    Targeted Pediatric High-Grade Glioma Therapy
    Glioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | WHO Grade IV Glioma
    United States, Australia, United Kingdom, Canada, Germany, Netherlands
  • Nationwide Children's Hospital
    Pfizer
    Not yet recruiting
    Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
    Glioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | WHO Grade III Glioma | WHO Grade IV Glioma | Infant Type Hemispheric Glioma | Diffuse Midline Glioma, H3K27-altered
    United States, Australia, Canada, Germany, Netherlands
  • National Cancer Institute (NCI)
    Suspended
    A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
    Glioblastoma | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Astrocytoma, Not Otherwise Specified | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Glioblastoma, Not Otherwise Specified
    United States, Canada, Australia, New Zealand
  • Rigel Pharmaceuticals
    Nationwide Children's Hospital
    Not yet recruiting
    Study of Olutasidenib and Temozolomide in HGG
    Astrocytoma | High Grade Glioma | Oligodendroglioma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | Spinal Tumor | Astrocytoma, Grade III | Astrocytoma, Grade IV | IDH1 Mutation | WHO Grade IV Glioma | Thalamus Tumor | IDH1 R132 | IDH1 R132C | IDH1 R132H and other conditions
    United States, Australia, United Kingdom, Canada, Germany, Netherlands
  • National Cancer Institute (NCI)
    Completed
    Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma
    Gliosarcoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma
    United States, Canada, Australia
  • Aminex Therapeutics, Inc.
    Recruiting
    Oral AMXT 1501 Dicaprate in Combination With IV DFMO
    Melanoma | Cervical Cancer | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Solid Tumor | Endometrial Cancer | Advanced Cancer | Diffuse Midline Glioma, H3 K27M-Mutant | Papillary Thyroid Cancer | Solid Carcinoma | Mesotheliomas Pleural | Glioma, Malignant | Ovary Cancer and other conditions
    United States, Australia
  • Novartis Pharmaceuticals
    Completed
    Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
    Glioblastoma | Astrocytoma | Anaplastic Astrocytoma | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma, Childhood and other conditions
    United States, Italy, Japan, Germany, Spain, France, Canada, Australia, Brazil, Israel, Russian Federation, Argentina, United Kingdom, Finland, Belgium, Denmark, Czechia, Sweden, Switzerland, Netherlands
  • Novartis Pharmaceuticals
    Recruiting
    Pediatric Long-Term Follow-up and Rollover Study
    Glioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditions
    United States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel, Brazil

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe